溶瘤病毒
转染
纳米载体
微泡
高尔基体
鞘磷脂
化学
癌细胞
细胞生物学
细胞内
细胞
受体
癌症研究
纳米颗粒
细胞膜
癌症
细胞培养
细胞表面受体
生物物理学
纳米技术
全身给药
HEK 293细胞
内体
脂质体
纳米医学
作者
Liming He,Ling Yang,Min Ren,Jie Wang,Wei Zhao,Chunli Yang,Pan Chunyan,Yunkun Xing,Shuai Yang,Hao Cheng,Xin Yuan,Ting Du,Meijuan Huang,Xian Jiang,苟马玲
出处
期刊:ACS Nano
[American Chemical Society]
日期:2026-10-10
卷期号:20 (42): 28169-28182
标识
DOI:10.1021/acsnano.6c00852
摘要
The Golgi apparatus (GA) has emerged as a promising target for cancer therapy. Commonly, therapeutics are guided to the GA by recognizing specific receptors on the GA membrane. However, the low and heterogeneous expression of these receptors often results in suboptimal targeting efficiency. Here, we present an oncolytic virus-like nanoparticle for GA targeting by exploiting sphingomyelin, an abundant component of the GA membrane. This nanoparticle consisted of a polymeric nanocarrier complexed with a plasmid encoding the secreting peptide-deleted α-hemolysin (αHL), a pore-forming protein with high affinity for sphingomyelin. The nanoparticle could transfect cancer cells to induce intracellular expression of αHL, enabling GA targeting through binding to GA-associated sphingomyelin while bypassing the cell membrane. Consequently, the transfected cells exhibited GA structural disassembly and underwent a pyroptosis-like programmed cell death with immunogenic characteristics. Notably, αHL-rich microvesicles were subsequently secreted, effectively killing neighboring tumor cells. Intratumoral administration of this formulation significantly suppressed subcutaneous tumor growth and elicited robust antitumor immunity, preventing tumor rechallenge. Furthermore, by incorporating iRGD-modified polymers, we constructed a tumor-targeting oncolytic virus-like nanoparticle with neutral surface charge. Following intravenous administration, this iRGD-modified nanoparticle could efficiently suppress tumor growth without causing obvious systemic toxicity. Collectively, this work presents a robust strategy for GA-targeting via sphingomyelin recognition, providing a potential approach for GA-targeted anticancer therapeutics.
科研通智能强力驱动
Strongly Powered by AbleSci AI